Emerging roles for intersectin (ITSN) in regulating signaling and disease pathways

International Journal of Molecular Sciences

Volumn 14, Issue 4, 2013, Pages 7829-7852

  Hunter, Michael P ^a   Russo, Angela ^a   O'Bryan, John P ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Alzheimer disease; Cancer; Cell signaling; Down syndrome; Endocytosis; Glioblastoma; Intersectin; Neuroblastoma; PI3KC2 ; Ras

Indexed keywords

INTERSECTIN; LATENT MEMBRANE PROTEIN 2; PROTEIN K15; PROTEIN TYROSINE KINASE; RAS PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; GUANOSINE TRIPHOSPHATASE; INTERSECTIN 1; PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE; PIK3C2B PROTEIN, HUMAN; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ALZHEIMER DISEASE; BINDING AFFINITY; CANCER STEM CELL; CARCINOGENESIS; DOWN SYNDROME; ENDOCYTOSIS; GENETIC CONSERVATION; GENETIC VARIABILITY; HUMAN; INTERSECTIN GENE; MORPHOGENESIS; NEUROBIOLOGY; NEUROBLASTOMA; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TWO HYBRID SYSTEM; ANIMAL; GENETICS; METABOLISM; PATHOLOGY;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ALZHEIMER DISEASE; ANIMALS; CLASS II PHOSPHATIDYLINOSITOL 3-KINASES; DOWN SYNDROME; ENDOCYTOSIS; GTP PHOSPHOHYDROLASES; HUMANS; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 84876342905     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14047829     Document Type: Review

References (118)

1. Sparks, A.B.; Hoffman, N.G.; McConnell, S.J.; Fowlkes, D.M.; Kay, B.K. Cloning of ligand targets: Systematic isolation of sh3 domain-containing proteins. Nat. Biotechnol. 1996, 14, 741-744.
2. Yamabhai, M.; Hoffman, N.G.; Hardison, N.L.; McPherson, P.S.; Castagnoli, L.; Cesareni, G.; Kay, B.K. Intersectin, a novel adaptor protein with two eps15 homology and five src homology 3 domains. J. Biol. Chem. 1998, 273, 31401-31407.
3. Yu, Y.; Chu, P.Y.; Bowser, D.N.; Keating, D.J.; Dubach, D.; Harper, I.; Tkalcevic, J.; Finkelstein, D.I.; Pritchard, M.A. Mice deficient for the chromosome 21 ortholog itsn1 exhibit vesicle-trafficking abnormalities. Hum. Mol. Genet. 2008, 17, 3281-3290.
4. Ma, Y.J.; Okamoto, M.; Gu, F.; Obata, K.; Matsuyama, T.; Desaki, J.; Tanaka, J.; Sakanaka, M. Neuronal distribution of ehsh1/intersectin: Molecular linker between clathrin-mediated endocytosis and signaling pathways. J. Neurosci. Res. 2003, 71, 468-477.
5. Guipponi, M.; Scott, H.S.; Chen, H.; Schebesta, A.; Rossier, C.; Antonarakis, S.E. Two isoforms of a human intersectin (itsn) protein are produced by brain-specific alternative splicing in a stop codon. Genomics 1998, 53, 369-376.
6. Pucharcos, C.; Casas, C.; Nadal, M.; Estivill, X.; de la Luna, S. The human intersectin genes and their spliced variants are differentially expressed. Biochim. Biophys. Acta 2001, 1521, 1-11.
7. Sengar, A.S.; Wang, W.; Bishay, J.; Cohen, S.; Egan, S.E. The eh and sh3 domain ese proteins regulate endocytosis by linking to dynamin and eps15. EMBO J. 1999, 18, 1159-1171.
8. Pucharcos, C.; Estivill, X.; de la Luna, S. Intersectin 2, a new multimodular protein involved in clathrin-mediated endocytosis. FEBS Lett. 2000, 478, 43-51.
9. Santolini, E.; Salcini, A.E.; Kay, B.K.; Yamabhai, M.; di Fiore, P.P. The EH network. Exp. Cell Res. 1999, 253, 186-209.
10. Fernandez-Chacon, R.; Achiriloaie, M.; Janz, R.; Albanesi, J.P.; Sudhof, T.C. Scamp1 function in endocytosis. J. Biol. Chem. 2000, 275, 12752-12756.
11. Martina, J.A.; Bonangelino, C.J.; Aguilar, R.C.; Bonifacino, J.S. Stonin 2: An adaptor-like protein that interacts with components of the endocytic machinery. J. Cell Biol. 2001, 153, 1111-1120.
12. Hussain, N.K.; Yamabhai, M.; Ramjaun, A.R.; Guy, A.M.; Baranes, D.; O'Bryan, J.P.; Der, C.J.; Kay, B.K.; McPherson, P.S. Splice variants of intersectin are components of the endocytic machinery in neurons and nonneuronal cells. J. Biol. Chem. 1999, 274, 15671-15677.
13. O'Bryan, J.P. Intersecting pathways in cell biology. Sci. Signal 2010, 3, re10.
14. Snyder, J.T.; Worthylake, D.K.; Rossman, K.L.; Betts, L.; Pruitt, W.M.; Siderovski, D.P.; Der, C.J.; Sondek, J. Structural basis for the selective activation of rho gtpases by dbl exchange factors. Nat. Struct. Biol. 2002, 9, 468-475.
15. Hussain, N.K.; Jenna, S.; Glogauer, M.; Quinn, C.C.; Wasiak, S.; Guipponi, M.; Antonarakis, S.E.; Kay, B.K.; Stossel, T.P.; Lamarche-Vane, N.; et al. Endocytic protein intersectin-l regulates actin assembly via cdc42 and n-wasp. Nat. Cell Biol. 2001, 3, 927-932.
16. Zamanian, J.L.; Kelly, R.B. Intersectin 1l guanine nucleotide exchange activity is regulated by adjacent src homology 3 domains that are also involved in endocytosis. Mol. Biol. Cell 2003, 14, 1624-1637.
17. McGavin, M.K.; Badour, K.; Hardy, L.A.; Kubiseski, T.J.; Zhang, J.; Siminovitch, K.A. The intersectin 2 adaptor links wiskott aldrich syndrome protein (wasp)-mediated actin polymerization to t cell antigen receptor endocytosis. J. Exp. Med. 2001, 194, 1777-1787.
18. Shen, G.; Whittington, A.; Song, K.; Wang, P. Pleiotropic function of intersectin homologue cin1 in cryptococcus neoformans. Mol. Microbiol. 2010, 76, 662-676.
19. Amores, A.; Force, A.; Yan, Y.L.; Joly, L.; Amemiya, C.; Fritz, A.; Ho, R.K.; Langeland, J.; Prince, V.; Wang, Y.L.; et al. Zebrafish hox clusters and vertebrate genome evolution. Science 1998, 282, 1711-1714.
20. Novokhatska, O.; Dergai, M.; Houssin, N.; Tsyba, L.; Moreau, J.; Rynditch, A. Intersectin 2 nucleotide exchange factor regulates cdc42 activity during xenopus early development. Biochem. Biophys. Res. Commun. 2011, 408, 663-668.
21. Tsyba, L.; Nikolaienko, O.; Dergai, O.; Dergai, M.; Novokhatska, O.; Skrypkina, I.; Rynditch, A. Intersectin multidomain adaptor proteins: Regulation of functional diversity. Gene 2011, 473, 67-75.
22. Tong, X.K.; Hussain, N.K.; de Heuvel, E.; Kurakin, A.; Abi-Jaoude, E.; Quinn, C.C.; Olson, M.F.; Marais, R.; Baranes, D.; Kay, B.K.; et al. The endocytic protein intersectin is a major binding partner for the ras exchange factor msos1 in rat brain. EMBO J. 2000, 19, 1263-1271.
23. Martin, N.P.; Mohney, R.P.; Dunn, S.; Das, M.; Scappini, E.; O'Bryan, J.P. Intersectin regulates epidermal growth factor receptor endocytosis, ubiquitylation, and signaling. Mol. Pharmacol. 2006, 70, 1643-1653.
24. Tsyba, L.; Gryaznova, T.; Dergai, O.; Dergai, M.; Skrypkina, I.; Kropyvko, S.; Boldyryev, O.; Nikolaienko, O.; Novokhatska, O.; Rynditch, A. Alternative splicing affecting the sh3a domain controls the binding properties of intersectin 1 in neurons. Biochem. Biophys. Res. Commun. 2008, 372, 929-934.
25. Dergai, M.; Tsyba, L.; Dergai, O.; Zlatskii, I.; Skrypkina, I.; Kovalenko, V.; Rynditch, A. Microexon-based regulation of itsn1 and src sh3 domains specificity relies on introduction of charged amino acids into the interaction interface. Biochem. Biophys. Res. Commun. 2010, 399, 307-312.
26. Kropyvko, S.; Gerasymchuk, D.; Skrypkina, I.; Dergai, M.; Dergai, O.; Nikolaienko, O.; Rynditch, A.; Tsyba, L. Structural diversity and differential expression of novel human intersectin 1 isoforms. Mol. Biol. Rep. 2010, 37, 2789-2796.
27. Shen, G.; Zhou, E.; Alspaugh, J.A.; Wang, P. Wsp1 is downstream of cin1 and regulates vesicle transport and actin cytoskeleton as an effector of cdc42 and rac1 in cryptococcus neoformans. Eukaryot. Cell 2012, 11, 471-481.
28. Wang, W.; Bouhours, M.; Gracheva, E.O.; Liao, E.H.; Xu, K.; Sengar, A.S.; Xin, X.; Roder, J.; Boone, C.; Richmond, J.E.; et al. Itsn-1 controls vesicle recycling at the neuromuscular junction and functions in parallel with dab-1. Traffic 2008, 9, 742-754.
29. Rose, S.; Malabarba, M.G.; Krag, C.; Schultz, A.; Tsushima, H.; di Fiore, P.P.; Salcini, A.E. Caenorhabditis elegans intersectin: A synaptic protein regulating neurotransmission. Mol. Biol. Cell 2007, 18, 5091-5099.
30. Roos, J.; Kelly, R.B. Dap160, a neural-specific eps15 homology and multiple sh3 domain-containing protein that interacts with drosophila dynamin. J. Biol. Chem. 1998, 273, 19108-19119.
31. Koh, T.W.; Verstreken, P.; Bellen, H.J. Dap160/intersectin acts as a stabilizing scaffold required for synaptic development and vesicle endocytosis. Neuron 2004, 43, 193-205.
32. Marie, B.; Sweeney, S.T.; Poskanzer, K.E.; Roos, J.; Kelly, R.B.; Davis, G.W. Dap160/intersectin scaffolds the periactive zone to achieve high-fidelity endocytosis and normal synaptic growth. Neuron 2004, 43, 207-219.
33. Thomas, S.; Ritter, B.; Verbich, D.; Sanson, C.; Bourbonniere, L.; McKinney, R.A.; McPherson, P.S. Intersectin regulates dendritic spine development and somatodendritic endocytosis but not synaptic vesicle recycling in hippocampal neurons. J. Biol. Chem. 2009, 284, 12410-12419.
34. Predescu, S.A.; Predescu, D.N.; Knezevic, I.; Klein, I.K.; Malik, A.B. Intersectin-1s regulates the mitochondrial apoptotic pathway in endothelial cells. J. Biol. Chem. 2007, 282, 17166-17178.
35. Predescu, S.A.; Predescu, D.N.; Timblin, B.K.; Stan, R.V.; Malik, A.B. Intersectin regulates fission and internalization of caveolae in endothelial cells. Mol. Biol. Cell 2003, 14, 4997-5010.
36. Okamoto, M.; Schoch, S.; Sudhof, T.C. Ehsh1/intersectin, a protein that contains eh and sh3 domains and binds to dynamin and snap-25. A protein connection between exocytosis and endocytosis? J. Biol. Chem. 1999, 274, 18446-18454.
37. Solomaha, E.; Szeto, F.L.; Yousef, M.A.; Palfrey, H.C. Kinetics of src homology 3 domain association with the proline-rich domain of dynamins: Specificity, occlusion, and the effects of phosphorylation. J. Biol. Chem. 2005, 280, 23147-23156.
38. Oh, P.; McIntosh, D.P.; Schnitzer, J.E. Dynamin at the neck of caveolae mediates their budding to form transport vesicles by gtp-driven fission from the plasma membrane of endothelium. J. Cell Biol. 1998, 141, 101-114.
39. Knezevic, I.; Predescu, D.; Bardita, C.; Wang, M.; Sharma, T.; Keith, B.; Neamu, R.; Malik, A.; Predescu, S. Regulation of dynamin-2 assembly-disassembly and function through the sh3a domain of intersectin-1s. J. Cell. Mol. Med. 2011, 15, 2364-2376.
40. Predescu, D.N.; Neamu, R.; Bardita, C.; Wang, M.; Predescu, S.A. Impaired caveolae function and upregulation of alternative endocytic pathways induced by experimental modulation of intersectin-1s expression in mouse lung endothelium. Biochem. Res. Int. 2012, 2012, 672705.
41. Evergren, E.; Gad, H.; Walther, K.; Sundborger, A.; Tomilin, N.; Shupliakov, O. Intersectin is a negative regulator of dynamin recruitment to the synaptic endocytic zone in the central synapse. J. Neurosci. 2007, 27, 379-390.
42. Pechstein, A.; Bacetic, J.; Vahedi-Faridi, A.; Gromova, K.; Sundborger, A.; Tomlin, N.; Krainer, G.; Vorontsova, O.; Schafer, J.G.; Owe, S.G.; et al. Regulation of synaptic vesicle recycling by complex formation between intersectin 1 and the clathrin adaptor complex ap2. Proc. Natl. Acad. Sci. USA 2010, 107, 4206-4211.
43. Dergai, O.; Novokhatska, O.; Dergai, M.; Skrypkina, I.; Tsyba, L.; Moreau, J.; Rynditch, A. Intersectin 1 forms complexes with sgip1 and reps1 in clathrin-coated pits. Biochem. Biophys. Res. Commun. 2010, 402, 408-413.
44. Henne, W.M.; Boucrot, E.; Meinecke, M.; Evergren, E.; Vallis, Y.; Mittal, R.; McMahon, H.T. Fcho proteins are nucleators of clathrin-mediated endocytosis. Science 2010, 328, 1281-1284.
45. Wong, K.A.; Wilson, J.; Russo, A.; Wang, L.; Okur, M.N.; Wang, X.; Martin, N.P.; Scappini, E.; Carnegie, G.K.; O'Bryan, J.P. Intersectin (itsn) family of scaffolds function as molecular hubs in protein interaction networks. PLoS One 2012, 7, e36023.
46. Morderer, D.; Nikolaienko, O.; Skrypkina, I.; Cherkas, V.; Tsyba, L.; Belan, P.; Rynditch, A. Endocytic adaptor protein intersectin 1 forms a complex with microtubule stabilizer stop in neurons. Gene 2012, 505, 360-364.
47. Soares, D.C.; Carlyle, B.C.; Bradshaw, N.J.; Porteous, D.J. disc1: Structure, function, and therapeutic potential for major mental illness. ACS Chem. Neurosci. 2011, 2, 609-632.
48. Jenna, S.; Hussain, N.K.; Danek, E.I.; Triki, I.; Wasiak, S.; McPherson, P.S.; Lamarche-Vane, N. The activity of the gtpase-activating protein cdgap is regulated by the endocytic protein intersectin. J. Biol. Chem. 2002, 277, 6366-6373.
49. Ahmad, K.F.; Lim, W.A. The minimal autoinhibited unit of the guanine nucleotide exchange factor intersectin. PLoS One 2010, 5, e11291.
50. Kintscher, C.; Wuertenberger, S.; Eylenstein, R.; Uhlendorf, T.; Groemping, Y. Autoinhibition of gef activity in intersectin 1 is mediated by the short sh3-dh domain linker. Protein Sci. 2010, 19, 2164-2174.
51. Jaffe, A.B.; Kaji, N.; Durgan, J.; Hall, A. Cdc42 controls spindle orientation to position the apical surface during epithelial morphogenesis. J. Cell Biol. 2008, 183, 625-633.
52. Martin-Belmonte, F.; Gassama, A.; Datta, A.; Yu, W.; Rescher, U.; Gerke, V.; Mostov, K. Pten-mediated apical segregation of phosphoinositides controls epithelial morphogenesis through cdc42. Cell 2007, 128, 383-397.
53. Rodriguez-Fraticelli, A.E.; Vergarajauregui, S.; Eastburn, D.J.; Datta, A.; Alonso, M.A.; Mostov, K.; Martin-Belmonte, F. The cdc42 gef intersectin 2 controls mitotic spindle orientation to form the lumen during epithelial morphogenesis. J. Cell Biol. 2010, 189, 725-738.
54. Tong, X.K.; Hussain, N.K.; Adams, A.G.; O'Bryan, J.P.; McPherson, P.S. Intersectin can regulate the ras/map kinase pathway independent of its role in endocytosis. J. Biol. Chem. 2000, 275, 29894-29899.
55. Mohney, R.P.; Das, M.; Bivona, T.G.; Hanes, R.; Adams, A.G.; Philips, M.R.; O'Bryan, J.P. Intersectin activates ras but stimulates transcription through an independent pathway involving jnk. J. Biol. Chem. 2003, 278, 47038-47045.
56. Adams, A.; Thorn, J.M.; Yamabhai, M.; Kay, B.K.; O'Bryan, J.P. Intersectin, an adaptor protein involved in clathrin-mediated endocytosis, activates mitogenic signaling pathways. J. Biol. Chem. 2000, 275, 27414-27420.
57. Das, M.; Scappini, E.; Martin, N.P.; Wong, K.A.; Dunn, S.; Chen, Y.J.; Miller, S.L.; Domin, J.; O'Bryan, J.P. Regulation of neuron survival through an intersectin-phosphoinositide 3'-kinase c2beta-akt pathway. Mol. Cell Biol. 2007, 27, 7906-7917.
58. Wong, K.A.; Russo, A.; Wang, X.; Chen, Y.-J.; Lavie, A.; O'Bryan, J.P. A new dimension to Ras function: A novel role for nucleotide-free Ras in class II phosphatidylinositol 3-kinase beta (PI3KC2β) regulation. PLoS One 2012, 7, e45360.
59. Okur, M.N.; Zhu, J.O.; Fong, C.W.; Martinez, N.; Garcia-Dominguez, C.; Rojas, J.M.; Guy, G.; O'Bryan, J.P. Intersectin 1 enhances cbl ubiquitylation of epidermal growth factor receptor through regulation of sprouty2-cbl interaction. Mol. Cell Biol. 2012, 32, 817-825.
60. Nikolaienko, O.; Skrypkina, I.; Tsyba, L.; Fedyshyn, Y.; Morderer, D.; Buchman, V.; de la Luna, S.; Drobot, L.; Rynditch, A. Intersectin 1 forms a complex with adaptor protein ruk/cin85 in vivo independently of epidermal growth factor stimulation. Cell. Signal 2009, 21, 753-759.
61. Frosi, Y.; Anastasi, S.; Ballaro, C.; Varsano, G.; Castellani, L.; Maspero, E.; Polo, S.; Alema, S.; Segatto, O. A two-tiered mechanism of egfr inhibition by ralt/mig6 via kinase suppression and receptor degradation. J. Cell Biol. 2010, 189, 557-571.
62. Anastasi, S.; Sala, G.; Huiping, C.; Caprini, E.; Russo, G.; Iacovelli, S.; Lucini, F.; Ingvarsson, S.; Segatto, O. Loss of ralt/mig-6 expression in erbb2-amplified breast carcinomas enhances erbb-2 oncogenic potency and favors resistance to herceptin. Oncogene 2005, 24, 4540-4548.
63. Xu, D.; Makkinje, A.; Kyriakis, J.M. Gene 33 is an endogenous inhibitor of epidermal growth factor (egf) receptor signaling and mediates dexamethasone-induced suppression of egf function. J. Biol. Chem. 2005, 280, 2924-2933.
64. Anastasi, S.; Baietti, M.F.; Frosi, Y.; Alema, S.; Segatto, O. The evolutionarily conserved ebr module of ralt/mig6 mediates suppression of the egfr catalytic activity. Oncogene 2007, 26, 7833-7846.
65. Lim, C.S.; Seet, B.T.; Ingham, R.J.; Gish, G.; Matskova, L.; Winberg, G.; Ernberg, I.; Pawson, T. The k15 protein of kaposi's sarcoma-associated herpesvirus recruits the endocytic regulator intersectin 2 through a selective sh3 domain interaction. Biochemistry 2007, 46, 9874-9885.
66. Dergai, O.; Dergai, M.; Skrypkina, I.; Matskova, L.; Tsyba, L.; Gudkova, D.; Rynditch, A. The lmp2a protein of epstein-barr virus regulates phosphorylation of itsn1 and shb adaptors by tyrosine kinases. Cell. Signal 2013, 25, 33-40.
67. Nishimura, T.; Yamaguchi, T.; Tokunaga, A.; Hara, A.; Hamaguchi, T.; Kato, K.; Iwamatsu, A.; Okano, H.; Kaibuchi, K. Role of numb in dendritic spine development with a cdc42 gef intersectin and ephb2. Mol. Biol. Cell. 2006, 17, 1273-1285.
68. Irie, F.; Yamaguchi, Y. Ephb receptors regulate dendritic spine development via intersectin, cdc42 and n-wasp. Nat. Neurosci. 2002, 5, 1117-1118.
69. Chabu, C.; Doe, C.Q. Dap160/intersectin binds and activates apkc to regulate cell polarity and cell cycle progression. Development 2008, 135, 2739-2746.
70. Morfini, G.A.; Burns, M.; Binder, L.I.; Kanaan, N.M.; LaPointe, N.; Bosco, D.A.; Brown, R.H., Jr.; Brown, H.; Tiwari, A.; Hayward, L.; et al. Axonal transport defects in neurodegenerative diseases. J. Neurosci. 2009, 29, 12776-12786.
71. Van der Crabben, S.; van Binsbergen, E.; Ausems, M.; Poot, M.; Bierings, M.; Buijs, A. Constitutional runx1 deletion presenting as non-syndromic thrombocytopenia with myelodysplasia: 21q22 itsn1 as a candidate gene in mental retardation. Leuk. Res. 2010, 34, e8-e12.
72. Lindstrand, A.; Malmgren, H.; Sahlen, S.; Schoumans, J.; Nordgren, A.; Ergander, U.; Holm, E.; Anderlid, B.M.; Blennow, E. Detailed molecular and clinical characterization of three patients with 21q deletions. Clin. Genet. 2010, 77, 145-154.
73. Yao, G.; Chen, X.N.; Flores-Sarnat, L.; Barlow, G.M.; Palka, G.; Moeschler, J.B.; McGillivray, B.; Morse, R.P.; Korenberg, J.R. Deletion of chromosome 21 disturbs human brain morphogenesis. Genet. Med. 2006, 8, 1-7.
74. Canfield, M.A.; Honein, M.A.; Yuskiv, N.; Xing, J.; Mai, C.T.; Collins, J.S.; Devine, O.; Petrini, J.; Ramadhani, T.A.; Hobbs, C.A.; et al. National estimates and race/ethnic-specific variation of selected birth defects in the united states, 1999-2001. Birth Defects Res. A Clin. Mol. Teratol. 2006, 76, 747-756.
75. Zigman, W.B.; Lott, I.T. Alzheimer's disease in down syndrome: Neurobiology and risk. Ment. Retard Dev. disabil. Res. Rev. 2007, 13, 237-246.
76. Pucharcos, C.; Fuentes, J.J.; Casas, C.; de la Luna, S.; Alcantara, S.; Arbones, M.L.; Soriano, E.; Estivill, X.; Pritchard, M. Alu-splice cloning of human intersectin (itsn), a putative multivalent binding protein expressed in proliferating and differentiating neurons and overexpressed in down syndrome. Eur. J. Hum. Genet. 1999, 7, 704-712.
77. Hunter, M.P.; Nelson, M.; Kurzer, M.; Wang, X.; Kryscio, R.J.; Head, E.; Pinna, G.; O'Bryan, J.P. Intersectin 1 contributes to phenotypes in vivo: Implications for down's syndrome. Neuroreport 2011, 22, 767-772.
78. Wilmot, B.; McWeeney, S.K.; Nixon, R.R.; Montine, T.J.; Laut, J.; Harrington, C.A.; Kaye, J.A.; Kramer, P.L. Translational gene mapping of cognitive decline. Neurobiol. Aging 2008, 29, 524-541.
79. Dunckley, T.; Beach, T.G.; Ramsey, K.E.; Grover, A.; Mastroeni, D.; Walker, D.G.; LaFleur, B.J.; Coon, K.D.; Brown, K.M.; Caselli, R.; et al. Gene expression correlates of neurofibrillary tangles in alzheimer's disease. Neurobiol. Aging 2006, 27, 1359-1371.
80. Blalock, E.M.; Geddes, J.W.; Chen, K.C.; Porter, N.M.; Markesbery, W.R.; Landfield, P.W. Incipient alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc. Natl. Acad. Sci. USA 2004, 101, 2173-2178.
81. Cataldo, A.M.; Peterhoff, C.M.; Troncoso, J.C.; Gomez-Isla, T.; Hyman, B.T.; Nixon, R.A. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic alzheimer's disease and down syndrome: differential effects of apoe genotype and presenilin mutations. Am. J. Pathol. 2000, 157, 277-286.
82. Keating, D.J.; Dubach, D.; Zanin, M.P.; Yu, Y.; Martin, K.; Zhao, Y.F.; Chen, C.; Porta, S.; Arbones, M.L.; Mittaz, L.; et al. Dscr1/rcan1 regulates vesicle exocytosis and fusion pore kinetics: Implications for down syndrome and alzheimer's disease. Hum. Mol. Genet. 2008, 17, 1020-1030.
83. Guipponi, M.; Scott, H.S.; Hattori, M.; Ishii, K.; Sakaki, Y.; Antonarakis, S.E. Genomic structure, sequence, and refined mapping of the human intersectin gene (itsn), which encompasses 250 kb on chromosome 21q22.1→q22.2. Cytogenet. Cell Genet. 1998, 83, 218-220.
84. Scappini, E.; Koh, T.W.; Martin, N.P.; O'Bryan, J.P. Intersectin enhances huntingtin aggregation and neurodegeneration through activation of c-jun-nh2-terminal kinase. Hum. Mol. Genet. 2007, 16, 1862-1871.
85. Wang, J.B.; Wu, W.J.; Cerione, R.A. Cdc42 and ras cooperate to mediate cellular transformation by intersectin-l. J. Biol. Chem. 2005, 280, 22883-22891.
86. Russo, A.; O'Bryan, J.P. Intersectin 1 is required for neuroblastoma tumorigenesis. Oncogene 2012, 31, 4828-4834.
87. Ma, Y.; Wang, B.; Li, W.; Liu, X.; Wang, J.; ding, T.; Zhang, J.; Ying, G.; Fu, L.; Gu, F. Intersectin1-s is involved in migration and invasion of human glioma cells. J. Neurosci. Res. 2011, 89, 1079-1090.
88. Ma, Y.; Wang, B.; Li, W.; Ying, G.; Fu, L.; Niu, R.; Gu, F. Reduction of intersectin1-s induced apoptosis of human glioblastoma cells. Brain Res. 2010, 1351, 222-228.
89. Marras, E.; Concari, P.; Cortellezzi, L.; Dondi, D.; de Eguileor, M.; Perletti, G. Involvement of pi3k in pkcepsilon-mediated oncogenic signal in rat colonic epithelial cells. Int. J. Oncol. 2001, 19, 395-399.
90. Koutros, S.; Schumacher, F.R.; Hayes, R.B.; Ma, J.; Huang, W.Y.; Albanes, D.; Canzian, F.; Chanock, S.J.; Crawford, E.D.; diver, W.R.; et al. Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer. Cancer Res. 2010, 70, 2389-2396.
91. Sato, N.; Fukushima, N.; Maitra, A.; Iacobuzio-Donahue, C.A.; van Heek, N.T.; Cameron, J.L.; Yeo, C.J.; Hruban, R.H.; Goggins, M. Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas. Am. J. Pathol. 2004, 164, 903-914.
92. Armstrong, S.A.; Staunton, J.E.; Silverman, L.B.; Pieters, R.; den Boer, M.L.; Minden, M.D.; Sallan, S.E.; Lander, E.S.; Golub, T.R.; Korsmeyer, S.J. Mll translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat. Genet. 2002, 30, 41-47.
93. Qian, Z.; Fernald, A.A.; Godley, L.A.; Larson, R.A.; Le Beau, M.M. Expression profiling of cd34+ hematopoietic stem/progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia. Proc. Natl. Acad. Sci. USA 2002, 99, 14925-14930.
94. Boller, D.; Doepfner, K.T.; de Laurentiis, A.; Guerreiro, A.S.; Marinov, M.; Shalaby, T.; Depledge, P.; Robson, A.; Saghir, N.; Hayakawa, M.; et al. Targeting pi3kc2beta impairs proliferation and survival in acute leukemia, brain tumours and neuroendocrine tumours. Anticancer Re. 2012, 32, 3015-3027.
95. Ramaswamy, S.; Tamayo, P.; Rifkin, R.; Mukherjee, S.; Yeang, C.H.; Angelo, M.; Ladd, C.; Reich, M.; Latulippe, E.; Mesirov, J.P.; et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc. Natl. Acad. Sci. USA 2001, 98, 15149-15154.
96. Su, A.I.; Welsh, J.B.; Sapinoso, L.M.; Kern, S.G.; dimitrov, P.; Lapp, H.; Schultz, P.G.; Powell, S.M.; Moskaluk, C.A.; Frierson, H.F., Jr.; et al. Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res. 2001, 61, 7388-7393.
97. Karnoub, A.E.; Weinberg, R.A. Ras oncogenes: Split personalities. Nat. Rev. Mol. Cell Biol. 2008, 9, 517-531.
98. Bremner, R.; Balmain, A. Genetic changes in skin tumor progression: Correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7. Cell 1990, 61, 407-417.
99. Modrek, B.; Ge, L.; Pandita, A.; Lin, E.; Mohan, S.; Yue, P.; Guerrero, S.; Lin, W.M.; Pham, T.; Modrusan, Z.; et al. Oncogenic activating mutations are associated with local copy gain. Mol. Cancer Res. 2009, 7, 1244-1252.
100. Spandidos, D.A.; Frame, M.; Wilkie, N.M. Expression of the normal h-ras1 gene can suppress the transformed and tumorigenic phenotypes induced by mutant ras genes. Anticancer Res. 1990, 10, 1543-1554.
101. Spandidos, A.; Wilkie, N.M. The normal human h-ras1 gene can act as an onco-suppressor. Br. J. Cancer Suppl. 1988, 9, 67-71.
102. Feig, L.A.; Cooper, G.M. Inhibition of nih 3t3 cell proliferation by a mutant ras protein with preferential affinity for gdp. Mol. Cell Biol. 1988, 8, 3235-3243.
103. Zhang, Z.; Wang, Y.; Vikis, H.G.; Johnson, L.; Liu, G.; Li, J.; Anderson, M.W.; Sills, R.C.; Hong, H.L.; Devereux, T.R.; et al. Wildtype kras2 can inhibit lung carcinogenesis in mice. Nat. Genet. 2001, 29, 25-33.
104. diaz, R.; Lue, J.; Mathews, J.; Yoon, A.; Ahn, D.; Garcia-Espana, A.; Leonardi, P.; Vargas, M.P.; Pellicer, A. Inhibition of ras oncogenic activity by ras protooncogenes. Int. J. Cancer 2005, 113, 241-248.
105. diaz, R.; Ahn, D.; Lopez-Barcons, L.; Malumbres, M.; Perez de Castro, I.; Lue, J.; Ferrer-Miralles, N.; Mangues, R.; Tsong, J.; Garcia, R.; et al. The n-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene. Cancer Res. 2002, 62, 4514-4518.
106. To, M.D.; Perez-Losada, J.; Mao, J.H.; Hsu, J.; Jacks, T.; Balmain, A. A functional switch from lung cancer resistance to susceptibility at the pas1 locus in kras2la2 mice. Nat. Genet. 2006, 38, 926-930.
107. To, M.D.; Wong, C.E.; Karnezis, A.N.; del Rosario, R.; di Lauro, R.; Balmain, A. Kras regulatory elements and exon 4a determine mutation specificity in lung cancer. Nat. Genet. 2008, 40, 1240-1244.
108. To, M.D.; Rosario, R.D.; Westcott, P.M.; Banta, K.L.; Balmain, A. Interactions between wild-type and mutant ras genes in lung and skin carcinogenesis. Oncogene 2012, doi:10.1038/onc.2012.404
109. Gonczy, P. Mechanisms of asymmetric cell division: Flies and worms pave the way. Nat. Rev. Mol. Cell Biol. 2008, 9, 355-366.
110. Neumuller, R.A.; Knoblich, J.A. dividing cellular asymmetry: Asymmetric cell division and its implications for stem cells and cancer. Genes. Dev. 2009, 23, 2675-2699.
111. Teckchandani, A.; Mulkearns, E.E.; Randolph, T.W.; Toida, N.; Cooper, J.A. The clathrin adaptor dab2 recruits eh domain scaffold proteins to regulate integrin beta1 endocytosis. Mol. Biol. Cell. 2012, 23, 2905-2916.
112. Powelka, A.M.; Sun, J.; Li, J.; Gao, M.; Shaw, L.M.; Sonnenberg, A.; Hsu, V.W. Stimulation-dependent recycling of integrin beta1 regulated by arf6 and rab11. Traffic 2004, 5, 20-36.
113. Naslavsky, N.; Rahajeng, J.; Sharma, M.; Jovic, M.; Caplan, S. Interactions between ehd proteins and rab11-fip2: A role for ehd3 in early endosomal transport. Mol. Biol. Cell 2006, 17, 163-177.
114. Lock, J.G.; Stow, J.L. Rab11 in recycling endosomes regulates the sorting and basolateral transport of e-cadherin. Mol. Biol. Cell 2005, 16, 1744-1755.
115. Palacios, F.; Price, L.; Schweitzer, J.; Collard, J.G.; D'Souza-Schorey, C. An essential role for arf6-regulated membrane traffic in adherens junction turnover and epithelial cell migration. EMBO J. 2001, 20, 4973-4986.
116. Fujita, Y.; Krause, G.; Scheffner, M.; Zechner, D.; Leddy, H.E.; Behrens, J.; Sommer, T.; Birchmeier, W. Hakai, a c-cbl-like protein, ubiquitinates and induces endocytosis of the e-cadherin complex. Nat. Cell Biol. 2002, 4, 222-231.
117. Malacombe, M.; Ceridono, M.; Calco, V.; Chasserot-Golaz, S.; McPherson, P.S.; Bader, M.F.; Gasman, S. Intersectin-1l nucleotide exchange factor regulates secretory granule exocytosis by activating cdc42. EMBO J. 2006, 25, 3494-3503.
118. Ding, X.; Yang, Z.; Zhou, F.; Hu, X.; Zhou, C.; Luo, C.; He, Z.; Liu, Q.; Li, H.; Yan, F.; et al. Human intersectin 2 (itsn2) binds to eps8 protein and enhances its degradation. BMB Rep. 2012, 45, 183-188.